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Abstract
Background: In a recent intervention study, the daily supplementation with 200 mg monomeric and oligomeric flavanols
(MOF) from grape seeds for 8 weeks revealed a vascular health benefit in male smokers. The objective of the present study
was to determine the impact of MOF consumption on the gene expression profile of leukocytes and to assess changes in
DNA methylation.
Methodology/Principal Findings: Gene expression profiles were determined using whole genome microarrays (Agilent)
and DNA methylation was assessed using HumanMethylation450 BeadChips (Illumina). MOF significantly modulated the
expression of 864 genes. The majority of the affected genes are involved in chemotaxis, cell adhesion, cell infiltration or
cytoskeleton organisation, suggesting lower immune cell adhesion to endothelial cells. This was corroborated by in vitro
experiments showing that MOF exposure of monocytes attenuates their adhesion to TNF-a-stimulated endothelial cells.
Nuclear factor kappa B (NF-kB) reporter gene assays confirmed that MOF decrease the activity of NF-kB. Strong inter-
individual variability in the leukocytes’ DNA methylation was observed. As a consequence, on group level, changes due to
MOF supplementation could not be found.
Conclusion: Our study revealed that an 8 week daily supplementation with 200 mg MOF modulates the expression of genes
associated with cardiovascular disease pathways without major changes of their DNA methylation state. However, strong
inter-individual variation in leukocyte DNA methylation may obscure the subtle epigenetic response to dietary flavanols.
Despite the lack of significant changes in DNA methylation, the modulation of gene expression appears to contribute to the
observed vascular health effect of MOF in humans.
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Introduction
A double-blind, randomized, placebo-controlled intervention
study recently revealed, that the daily consumption of monomeric
and oligomeric flavanols (MOF) derived from seeds of grapes (Vitis
vinifera L.) for 8 weeks accomplish a vascular health benefit in male
smokers [1]. This potential cardiovascular health benefit is in
agreement with a recent study that showed an association between
the intake of flavanols and reduced risk of coronary heart diseases
[2]. However, comprehensive understanding of the biological
activity of flavanols including their mechanisms of action in
humans is still enigmatic [3].
Over the past years, in vitro and in vivo studies have shown that
polyphenols modulate the activity of cell signalling proteins,
transcription factors and consequently the expression of both,
mRNA and miRNA [4]. For example, in animal models (mice and
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rats), supplementation of a diet with quercetin, naringenin or
curcumin at nutritionally relevant doses altered the expression of
hundreds of genes in lung, aorta or liver [5,6,7]. In vitro,
polyphenols impact the expression of genes in various cell types.
It has been demonstrated that flavanone metabolites at physio-
logical concentrations can modulate the expression of genes
involved in inflammation in tumor necrosis factor (TNF)-a-
stimulated human umbilical vein endothelial cells (HUVECs)
[8]. Exposure of human monocytes to green tea polyphenols
affected the expression of genes related to atherosclerosis
development, such as CD36, LXR-a, MYC or LDL-R [9]. In
human hepatocytes polyphenols from red grape juice were able to
counteract the LDL-induced changes in gene expression of the
LDL receptor, hydroxymethylglutaryl-CoA (HMG-CoA) reduc-
tase and the transcription factor sterol regulatory element-binding
protein (SREBP)-1, a key regulator of lipid homeostasis. Also genes
such as ICAM1, MCP1, IL6 or IL1b of which expression is
controlled by nuclear factor kappa B (NF-kB) and of which
transcriptional activation is critical in a number of pathologies,
including cardiovascular diseases, are differentially expressed in
the presence of polyphenols [10,11]. However, only a few studies
have been published up to now describing the genomic impact of
polyphenols and polyphenol-rich foods in humans. It has been
observed that the daily intake of 150 mg quercetin for 2 weeks
significantly affected the expression of 788 genes in CD14-positive
monocytes, genes related to immune system, apoptosis or cell
signalling pathways [12]. Consumption of orange juice rich in
hesperidin or hesperidin alone for 4 weeks by healthy, middle-
aged, moderately overweight men significantly affected over 3000
and 1800 genes respectively. These genes were involved in the
regulation of chemotaxis, cell adhesion, lipid transport and their
expression profile could be considered as anti-inflammatory and
anti-atherogenic [13]. More recently, in a double-bind, random-
ized cross-over trial in menopausal women isoflavones affected in
peripheral blood mononuclear cells the expression of 357 genes
which are involved in inflammation, oxidative phosphorylation
and cell cycle [14].
In addition to the impact of polyphenols on the expression of
genes, recent data suggest that polyphenols could also modulate
DNA methylation at multiple levels [15,16]. Furthermore,
different lifestyle factors such as diet and smoking have been
associated with DNA methylation changes in cancer and chronic
inflammation related diseases such as metabolic syndrome,
diabetes or cardiovascular diseases [17,18,19,20,21]. Whether diet
specific epigenetic changes can also be detected in circulating
blood leukocytes or contribute to disease progression is a hot
research topic [22,23,24,25]. The correlation of genome-wide data
on DNA methylation and gene expression unveiled that methyl-
ation of promoter regions is frequently associated with transcrip-
tional repression of genes being under control of this promoter
[26,27]. On the other hand it was also observed that this simple
relation is not universally applicable but rather depends on genes,
cell types, tissues and genetic variants [28,29,30]. The majority of
these findings are derived from in vitro experiments with cell
cultures. However, data that directly link DNA methylation
changes with alterations in gene expression in humans are scarce.
A first randomized controlled clinical study recently reported that
the controlled intake of a cocoa extract by humans at cardiovas-
cular risk is able to affect both global DNA methylation of white
blood cells, as well as the expression of individual genes involved in
the regulation of DNA methylation [25]. Whether transcriptional
changes induced by the regular consumption of dietary polyphe-
nols on a whole genome level can be related to changes of the
methylome in white blood cells has yet not been investigated.
Taken together, it can be hypothesized that dietary flavanols are
able to modulate the expression of genes being associated with
CVD pathomechanisms via changes in the DNA methylation
pattern of these genes. The present study aimed at investigating
the impact of an 8 weeks controlled dietary intervention with
MOF in smokers, i.e. humans with an increased risk of CVD, on
genome-wide changes in leukocytes’ gene expression and relate
them to changes in DNA methylation.
Materials and Methods
Clinical trial
Details on the design, protocol and conduction of the clinical
study are provided elsewhere [1]. In brief, non-obese, healthy male
smokers in an age between 30 and 60 years and smoking 10 and
more cigarettes per day for at least 5 years were included in the
trial. The study was approved by the Medical Ethical Committee
of the Maastricht University and Academic Hospital Maastricht,
The Netherlands (ClinicalTrials.gov, NCT00742287) and con-
ducted according to the World Medical Association Declaration of
Helsinki of 1975, revision 2008. All subjects provided their written
informed consent to participate in this study. For the present
investigations blood samples of 13 men were available before and
after an intervention of 8 weeks with a daily intake of two capsules
containing 100 mg MOF from Vitis vinifera L. seeds (MASQUE-
LIER’s Original OPCs, INC BV, Loosdrecht, The Netherlands).
The composition of the MOF capsules is specified in [1]. Basically,
the intake of 2 capsules per day provided each subject with
51.3 mg total catechins ((+)2catechin, (2)-epicatechin and (2)2
epicatechin-3-O-gallate), 55 mg total flavanol dimers (proantho-
cyanidin B1, B2, B3 and B4) and 93.8 mg total tri-, tetra- and
pentameric proanthocyanidins. During the intervention period
subjects maintained their usual smoking, dietary and lifestyle
habits, complied with the regular intake of the capsules and did not
experience any severe side effects.
The anthropometric and clinical characteristics of the volun-
teers from which the blood samples were derived for the analysis of
gene expression and DNA methylation are given in table 1. An
overview of the subsequent data analysis strategy and selection of
RNA and DNA samples included in our data analyses is
summarized in the flow chart (figure 1). Differential blood
counts [1] of the samples for which the whole genome methylation
state could be determined did not indicate any significant changes
in the total number of leukocytes and the various subpopulations
during the 8 weeks intervention period (table 2).
Sample collection, total RNA and genomic DNA
extraction
At baseline and after 8 weeks of MOF supplementation freshly
collected blood was added to RNALater (Ambion, Austin, TX,
USA) and stored at 280uC until further extraction of RNA or
genomic DNA (gDNA). Total RNA was isolated from blood by
means of the RiboPure-Blood kit (Ambion, Austin, TX, USA) in
accordance with the manufacturer’s instructions. RNA purity and
concentrations were determined by UV-VIS spectrophotometry
(NanoDrop, Thermo Fisher Scientific Inc, Wilmington, DE,
USA), and confirmed using the Agilent Bioanalyzer (Agilent
Technologies Inc., Santa Clara, CA, USA). gDNA from EDTA-
treated blood was extracted by a DNeasy blood & tissue kit
(Qiagen, Courtaboeuf, France). DNA purity and concentrations
were determined by UV-VIS spectrophotometry (NanoDrop,
Thermo Fisher Scientific Inc, Wilmington, DE, USA) and stored
at 280uC until further use.
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Figure 1. Flow chart of the sample analyses in the study.
doi:10.1371/journal.pone.0095527.g001
Table 1. Anthropometric and clinical characteristics of the male volunteers.
Men (n=13) Clinical reference values
Age, y 48 (30–58) n.a.
BMI, kg/m 25 (18–28) ,30
Years of smoking 28 (14–42) n.a.
Cigarettes/day 16 (10–25) n.a.
Pack years 19 (7–52) n.a.
SBP, mmHg 115 (103–124) ,140
DBP, mmHg 74 (60–85) ,90
Heart rate, beats/min 55 (50–66) 60–100
tChol, mmol/L 5.7 (4.0–7.1) #5.0
LDL, mmol/L 3.9 (2.5–5.5) #2.5
HDL, mmol/L 1.2 (0.8–2.0) 0.9–1.7
TG, mmol/L 1.2 (0.9–4.0) ,2.0
CRP, mg/L 1.7 (0.6–5.6) ,10
Fibrinogen, g/L 3.4 (2.4–4.8) 2.0–4.0
Values are median (range); BMI, body mass index; CRP, C-reactive protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; n.a.,
not applicable; SBP, systolic blood pressure; tChol, total cholesterol; TG, triglycerides.
Clinical reference values are Dutch reference values ‘‘clinical chemistry’’ (www.fk.cvz.nl) and from the Dutch General Practitioner Guidelines (https://www.nhg.org/stand
aarden/volledig/cardiovasculair-risicomanagement [68]).
doi:10.1371/journal.pone.0095527.t001
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Microarray analysis
Fifty ng of total RNA extracted from each sample were
amplified and fluorescently labelled to produce Cy5 or Cy3 cRNA
using the Low Input Quick Amp Labeling two-color kit (Agilent,
USA) in the presence of spike-in two colours control. After
purification, 825 ng of labelled cRNA/sample were hybridized
onto G4845A Human GE 4x44K v2 microarrays (Agilent, USA)
according to the manufacturer’s instructions. The G4845A
Human GE 4x44K v2 microarray contains 27,958 Entrez Gene
RNAs sequences. After hybridization, microarrays were scanned
with Agilent G2505 scanner (Agilent, USA) and data were
extracted with Feature Extraction software (Agilent, USA) using
Lowess normalization. Statistical analyses were performed using
the free R 2.1 software (http://www.r-project.org) after controlling
the variance of each gene. Data were analyzed with a Student’s t
test to detect differentially expressed genes and the probability
values were adjusted using the Benjamini-Hochberg correction for
multiple testing at 0.1 to eliminate false positives. Genes selected
by these criteria are referred to as the ‘‘differentially expressed
genes’’. Microarray data have been deposited in accordance to the
MIAME guidelines in the public Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/), accession
number GSE54325 and GSE54643.
Biological interpretation
Gene ontology (GO) annotations of biological processes for
differentially expressed genes were conducted using MetaCore
(https://portal.genego.com) and BioMart data mining tool of
Ensembl database (http://www.ensembl.org/biomart/). To ex-
tract maximum biological information of differentially expressed
genes, together with GO, genes were also classified according to
their role(s) in cellular or metabolic pathways using Kyoto
Encyclopedia of Genes and Genomes (KEGG) (http://www.
genome.jp/kegg/pathway.html) and MetaCore (https://portal.
genego.com) databases. Potential transcription factors involved
in the regulation of differentially expressed genes were searched
using network algorithms for transcription factors development in
MetaCore software.
Human monocyte to endothelial cell adhesion in vitro
assay
Primary human umbilical vein endothelial cells (HUVECs;
Lonza, Walkersville, MD, USA) were used at passage 5 and were
cultured in a phenol-red-free endothelial growth medium (EGM)
supplemented with 2% fetal bovine serum (FBS), 0.4% fibroblast
growth factor, 0.1% vascular endothelial growth factor, 0.1%
heparin, 0.1% insulin-like growth factor, 0.1% ascorbic acid, 0.1%
epidermal growth factor, and 0.04% hydrocortisone (all from
Lonza). Experiments were performed in 24 well plates (Becton
Dickinson, Le Pont de Claix-Cedex, France). A human monocytic
cell line (THP-1) (ATCC, Manassas, VA, USA) was cultured in
RPMI 1640 medium (Pan Biotech, Aidenbach, Germany)
supplemented with 2% FBS (Sigma, Saint Quentin Fallavier,
France). Both cultures were maintained at 37uC and 5% CO2.
For cell adhesion assays, when HUVECs reached 60–70%
confluence, monocytes were exposed for 24 h to MOF dissolved in
mQ to a final concentration of 0.05 mg/ml, 0.5 mg/ml and 5 mg/
ml. After 24 h, the confluent HUVEC monolayer was stimulated
for 4 h with TNF-a at 0.1 ng/ml or PBS/BSA (0.01%, negative
control). Following TNF-a stimulation, 50 ml of a 56106/ml THP-
1 suspension with or without pre-exposure to MOF, was added to
each well and cells were further incubated for 1 h. Non-adhering
THP-1 cells were rinsed away with PBS. The remaining cells were
fixed and stained with crystal violet 0.5% (m/V) in ethanol (Sigma,
France). The number of attached monocytes was counted for each
well in three random microscopic fields defined by an eyepiece.
Triplicates for each condition were performed in three indepen-
dent experiments.
NF-kB reporter gene in vitro assay
A human monocytic cell line stably transfected with a luciferase
reporter containing three NF-kB-binding sites (U937-3xB-LUC
cells) was used to investigate the effects of MOF on NF-kB
mediated gene expression [31]. Cells were cultured in RPMI-1640
medium supplemented with L-glutamine (2 mM), penicillin
(50 U/ml), streptomycin (50 mg/ml), hygromycin (75 mg/ml)
and 10% fetal bovine serum at 37uC and 5% CO2. For
experiments cells were transferred to complete medium without
antibiotics in 24 well plates. For lipopolysaccharide (LPS)-induced
NF-kB activity, monocytes were in vitro differentiated to macro-
phages by 24 h PMA treatment (10 ng/ml) after which the
medium was replaced by complete medium without PMA.
Subsequently, cells were incubated with MOF (0.05–5 mg/ml) or
vehicle control (mQ) for 30–60 min, followed by the addition of
LPS (1 mg/ml) and an additional incubation of 4–6 h prior to
measuring luciferase reporter-gene expression. In another exper-
imental set-up monocytes were differentiated to macrophages by
24 h PMA (10 ng/ml) treatment in the presence or absence of
MOF (5 mg/ml). After replacement of the medium, macrophages
were stimulated with LPS (1 mg/ml) for 6 h before luciferase
reporter-gene expression was determined. Cell lysis and luciferase
(luc) assays were carried out according to the protocol of Promega
Table 2. Total and differential leukocytes count of the samples used for DNA-methylation analysis.
Baseline (n=10) 8 weeks (n =10) P value Clinical reference values
Leukocytes, 109/L 863 862 0.620 4–106109/L
Neutrophils, 109/L 4 (3.2–11.7) 4.2 (2.8–6.7) 0.912 2–7.26109/L
Lymphocytes, 109/L 2.360.6 2.360.6 0.868 1.0–4.06109/L
Monocytes, 109/L 0.660.2 0.660.2 0.403 0.15–0.96109/L
Eosinophil granulocytes, 109/L 0.360.1 0.360.1 0.841 0–0.56109/L
Basophil granulocytes, 109/L 0.0460.03 0.0460.03 0.853 0–0.156109/L
Values are median (range) in case of non-normally distributed data or mean 6 standard deviation (SD) in case of normally distributed data. Statistically significant
differences between baseline and the end of the 8 week intervention were tested with two-tailed independent samples Student’s t-test in case of normally distributed
data or with the Mann-Whitney U-test in case of non-normally distributed data. P,0.05 is set as level of significance. Clinical reference values are Dutch reference values
‘‘clinical chemistry’’ (http://www.fk.cvz.nl).
doi:10.1371/journal.pone.0095527.t002
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Corp. (Madison, WI, USA). The preparation of luciferase (luc)
reagent was described previously [32]. Cell viability was deter-
mined by trypan blue exclusion.
DNA-methylation arrays
Bisulphite converted DNA from the subjects was hybridized to
the Illumina HumanMethylation450 BeadChip arrays. For each
sample, 1 mg of genomic DNA was bisulfite-converted using an EZ
DNA methylation Kit (ZYMO research) according to the
manufacturer’s recommendations. Converted genomic DNA was
eluted in 22 ml of elution buffer. DNA methylation level was
measured using the Illumina Infinium HD Methylation Assay
(Illumina) according to the manufacturer’s instructions. Briefly,
4 mg of bisulfite-converted DNA was isothermally amplified
overnight (20–24 h) and fragmented enzymatically. Precipitated
DNA was resuspended in hybridization buffer and dispensed onto
the Infinium HumanMethylation450 BeadChips (12 samples/
chip) using a Freedom EVO robot (Tecan). The hybridization
procedure was performed at 48uC overnight (16–20 h) using an
Illumina Hybridization oven. After hybridization, free DNA was
washed away and the BeadChips were processed through a single
nucleotide extension followed by immunohistochemistry staining
using a Freedom EVO robot (Tecan). Finally, the BeadChips were
imaged using an Illumina iScan. Illumina data have been
deposited in accordance to the MIAME guidelines in the public
Gene Expression Omnibus (GEO) database (http://www.ncbi.
nlm.nih.gov/geo/), accession number GSE 54690.
Illumina data analysis
Raw Illumina data were filtered by Genomestudio software and
R packages Bioconductor Minfi and Rnbeads to remove low
quality data using a detection P-value threshold of 0.05. Cross-
reactive probes (i.e. targeting several genomic locations) and probes
containing SNPs were filtered out using the extended annotation
provided by Price et al [33] (see [34] for a detailed description). b-
values were computed using the formula b-value =M/[U+M]
where M and U are the raw ‘‘methylated’’ and ‘‘unmethylated’’
signals, respectively. Beta-values were corrected for the type I and
type II bias using the peak-based correction [34].
DNA CpG pyrosequencing
Bisulfite modification of 1 mg of gDNA was performed using the
EpiTect Fast DNA Bisulfite kit (Qiagen) per manufacturer’s
protocol. Forward, reverse, and sequencing primers were designed
using the Pyromark Assay Design Software (Qiagen Inc., Valencia,
CA). Bisulfite converted DNA was diluted 1:50 with water. A
touchdown PCR program was used to amplify the DNA using the
HotStarTaq kit (Qiagen Inc., Valencia, CA). PCR cycling
conditions were as follows: denaturation at 95uC for 30 seconds,
annealing (temperature varied depending upon primer and
replication cycle) for 30 seconds, extension at 72uC for 1 minute
for 45 cycles followed by a final extension at 72uC for 10 minutes.
Samples were then stored at 4uC. The following primer sets were
used for DNA CpG pyrosequencing: CCR6 forward primer
TTGTGTTTGGAGTAGTGTTTAGT, reverse primer Biotin-
CCTAAATCTTCCACCTCCTCTTTATACCAC, sequencing
primer TGTTTGGAGTAGTGTTTAGTA; MAFB forward
primer AGGGAATTGAGGGAGGAGAG, reverse primer Bio-
tin-ACCCACCCCCCTACCCTACAAA, sequencing primer
GTGATTTGGTTTAGAGGT; PCDHB4 forward primer
AGATTTTTGGTTAGATGGGTTATAAAG, reverse primer
Biotin-ATTCATCCAAACAAACAAATATTAACC, sequencing
primer ATGGGTTATAAAGGAGT. CpG methylation percent-
ages were calculated using the height of the T and C peaks at the
methylation site and applying the formula (C/C+T)6100 as
implemented in the Pyromark CpG software (version 1.0.11).
Statistics
The effects of MOF on monocyte-endothelial cell adhesion were
analysed by means of two-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparisons post-hoc tests.
To examine the effects of MOF on NF-kB reporter gene activity
or DNA methylation either one-way or two-way ANOVA was
used as indicated. Significant differences were identified using
Bonferroni’s or Tukey’s multiple comparisons post-hoc tests
(reporter gene assay data) or Bonferroni’s post-hoc test (DNA
methylation), as indicated. For correlation analysis, the Pearson
coefficient was calculated. The level of statistical significance was
set to P,0.05 for all analyses. Statistical analyses were performed
with GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA).
Results
Baseline characteristics of the included male smokers
Table 1 shows that the median BMI of the included volunteers
was at the upper limit of normal, and none of subjects was obese,
i.e. having a BMI $30 kg/m2. All volunteers were normotensive
and had elevated serum LDL-cholesterol levels. In addition, the
majority of these persons (n = 10) had total cholesterol concentra-
tions above 5 mmol/l serum. The white blood cell composition
did not significantly fluctuate during the 8-week intervention
period (table 2).
Nutrigenomic analysis of transcriptional effects of MOF
supplementation in blood leukocytes
RNA samples from the blood cells of 13 volunteers at baseline
and after 8 weeks of MOF consumption was used for the
microarray study (figure 1). The concentration of total RNA per
blood sample was 47.5 ng in average. However, 2 RNA
extractions were eliminated due to low RNA yields. Following
hybridization of microarrays, 4 samples did not meet quality
control conditions and were eliminated. After paired statistical
analysis followed by false positive correction of the data,
modification in the gene expression profile was observed following
8 weeks consumption of MOF. Statistical analyses revealed 864
differentially expressed genes (p.0.05 and corrected p,0.1)
(table S1). Out of the 864 genes, 445 were identified as down-
regulated and 419 as up-regulated, with expression changes
varying from 21.32 to 1.72.
To identify the biological function in which these genes are
involved, gene ontology, pathway and gene network analyses were
performed. Gene ontology revealed that differentially expressed
genes are involved in different over-represented cellular processes
(table S2). Among these processes are those regulating macro-
phage-derived foam cell differentiation, chromatin organization,
cell cycle, chemotaxis, regulation of cell-cell adhesion, regulation
of metabolic processes, regulation of lipid storage and regulation of
cytoskeleton organization. To further refine the biological
functions in which differentially expressed genes are implicated,
the genes were placed according to their role(s) in cellular or
metabolic pathways. Pathway analyses of the differentially
expressed genes using MetaCore software identified 59 signifi-
cantly over-represented cellular pathways (table S3). Among
these 59 pathways, 19 are involved in the regulation of
inflammation, cell adhesion, cell cycle and cytoskeleton remodel-
ling (figure 2). Pathway analysis using KEGG database also
revealed pathways such as cell adhesion, MAPK signalling
pathway, regulation of actin cytoskeleton, cell cycle, chemokine
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signalling pathway, focal adhesion and leukocyte transendothelial
migration. Among the genes present in these pathways are
CXCL12, SCRIB, PDGFRL, FERMT3, ICAM1 or VCAM1. As for
MetaCore, KEGG database pathways also indicated cell adhesion,
chemotaxis or regulation of cellular cytoskeleton as significantly
altered pathways upon MOF supplementation. Moreover, bioin-
formatic analyses were performed on the differentially expressed
genes with the aim to identify transcription factors that could be
modulated by MOF and which are potentially involved in the
regulation of the expression of the identified genes. Among the
identified transcription factors are SP1, p53, AP1 and NF-kB. A
network of genes centred to NF-kB and affected by the MOF
supplementation is presented in figure 3.
Effects of MOF on monocyte adhesion to human vascular
endothelial cells in vitro
To substantiate the findings from the microarray analyses that
exposure of circulating white blood cells to MOF modifies the
expression of genes towards reduced immune cell-endothelial cell
interaction, we performed in vitro monocyte to endothelial cell
adhesion assays (figure 4). We observed that the number of
monocytes adhering to HUVECs without TNF-a stimulation was
low. Stimulation of the endothelial cells with 0.1 ng/ml TNF-a
significantly induced monocyte adhesion to endothelial cells by a
factor of 6. Interestingly, pre-exposition of the monocytes to
different concentrations of MOF significantly reduced their
adhesion to TNF-a-stimulated endothelial cells by 21% to 34%
(figure 4). However, under these experimental conditions, we did
not observe a dose-dependent inhibition.
Figure 2. Significant pathways (MetaCore MetaCore Bioinformatics software from Thomson Reuters, https://portal.genego.com/) of
the gene expression profiles of leukocytes after consumption of monomeric and oligomeric flavanols (MOF) derived from grape
seeds involved in immunity, cell signalling and cell adhesion.
doi:10.1371/journal.pone.0095527.g002
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Effects of MOF on NF-kB activity in human monocytes/
macrophages in vitro
To experimentally confirm the predicted impact of MOF on the
activity of the transcription factor NF-kB, we performed NF-kB-
specific reporter gene assays in the U937 human macrophage cell
line. In vitro differentiated U937-3xB-LUC macrophages were left
untreated or treated with different concentrations of MOF for 30
or 60 minutes, respectively (figure 5 A and B). Hereafter, cells
were exposed to LPS (1 mg/ml) for 4, 5 or 6 h after which cells
were lysed and analysed for luciferase reporter-gene expression. As
presented in figure 5, a moderate but significant dose- (figure 5
A) and time-dependent (figure 5 B) reduction in NF-kB reporter
gene activity could be observed upon combined treatment with
LPS and MOF. Alternatively, to evaluate persistent ‘‘memory’’
effects of MOF on NF-kB-dependent gene expression, cells were
either treated with PMA (10 ng/ml) alone or co-treated with
5 mg/ml MOF and PMA (10 ng/ml) during 24 h monocyte-
macrophage differentiation. Twenty-four hours following replace-
ment of the medium, cells were stimulated for 6 h with LPS (1 mg/
ml). Cells differentiated in the presence of both, PMA and MOF,
revealed a significant lower maximal NF-kB response upon
subsequent LPS stimulation (figure 5 C).
Intra- and inter-individual changes in genome-wide DNA
methylation analysis of blood samples before and after
MOF supplementation
To evaluate whether transcriptional changes observed in the
microarray experiment correspond with epigenetic changes in
DNA methylation, gDNA from 10 volunteers at baseline and after
8 weeks of MOF consumption was analyzed for gene-specific
DNA methylation changes by Illumina 450K bead array. 99% of
the CpG probes resulted in reliable hybridisation signals (P,0.01).
Low (b-value,0.2), medium (0.2,b,0.6) and highly methylated
Illumina CpG probes (b.0.6) of respectively MAFB, PCDHB4 and
Figure 3. An NF-kB biological network based on the differentially expressed genes in circulatory cells obtained from MetaCoreTM
network software and the ‘‘Analyze’’ network algorithms. Dots in the right corner of a gene indicate differential expression, blue for down-
regulated genes and red for up-regulated genes.
doi:10.1371/journal.pone.0095527.g003
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CCR6 were selected for further validation by CpG pyrosequencing
(figure 6). This confirmed good overall correlation between
Illumina CpG array and CpG pyrosequencing based quantifica-
tion of DNA methylation trends, although small shifts (under/
overestimation) could be observed for some CpG probes on the
Illumina platform. Upon comparison of b-values of 450K CpG
probes at baseline and after 8 weeks of MOF consumption, CpG
probes were selected which revealed minimal 10% increase or
decrease (i.e. 0.1 difference in b-value) between both conditions in
different individuals or at the group level. Intra-individual DNA
methylation before and after MOF supplementation of 2
representative subjects is illustrated in figure 7A. Typically,
approx. 0.03 to 3% of the 450K CpG probes changed in different
individuals during the 8 weeks MOF supplementation (data not
shown). However, taking into account that experimental variation
of sample replicates in the Illumina array may already result in
false positive changes in 1% of the 450K CpG probes (P,0.01), no
statistical significant DNA methylation changes could be associ-
ated with the MOF supplementation due to the small sample size
(n = 10) and lack of replicate measurements.
Furthermore, upon comparing b-values of 450K CpG probes at
baseline between subjects, we observed a remarkable epigenetic
variation, since up to 10% of the CpG probes revealed more than
10% difference in DNA methylation (figure 7B). This difference
could not be attributed to fluctuations in leukocytes composition
and numbers as this was found to be consistent between
individuals before and after the MOF intervention (table 2).
Relative number of intra- versus inter-individual changes in CpG
probe DNA methylation (.10%) for all individuals before/after
MOF supplementation is summarized in table S4. Although
cardiovascular risk factors such as smoking, hypertension, and
high pulse seemed to change DNA methylation of various genes
related to cell adhesion pathways, we could not associate statistical
significant DNA methylation changes with specific lifestyle factors,
due to the small cohort size (data not shown).
Changes in DNA methylation of genes associated with
cardiovascular pathways during 8 weeks MOF
supplementation
In order to examine the DNA methylation state of various
regions of individual genes during the 8 weeks intervention we
selected the following genes CXCL12, SCRIB, PDGFRL, FERMT3,
ICAM1 and VCAM1. These genes are involved in pathways related
to cardiovascular diseases and have been shown to be differentially
expressed during the 8 weeks MOF intake. Figure 8 shows the
DNA methylation state of individual CpG in different gene regions
before and after the MOF intervention. Interestingly, within an
individual gene such as CXCL12, highly variable CpG methylation
(low-medium-high methylation) could sometimes be observed for
specific probes across 59-UTR, promoter, gene body or 39-UTR
regions. No major DNA methylation changes (.10%) could be
detected in any of the differentially expressed genes at group level,
which is in line with our global DNA methylation analysis
(Figure 7).
Discussion
In animal models and in vitro studies, the potential beneficial
effect of flavanols on the prevention of different diseases including
cancer, neurodegenerative and cardiovascular diseases has been
demonstrated [35]. This effect seems to be related to their capacity
to modulate the activity of different enzymes, cell signalling
proteins and expression of genes and proteins. A recent meta-
analysis has revealed that grape seed extract appears to
significantly lower systolic blood pressure and heart rate [36],
and we have recently shown that consumption of grape seed-
derived MOF presented an overall vascular health benefit [1]. The
potential mechanism of action underlying these effects in humans
is still largely unknown. In this study, we demonstrated that the
consumption of MOF affected blood leukocytes gene expression
without a significant modulation of changes in DNA methylation.
Figure 4. Effect of incubation of THP1 monocytes with MOF concentrations ranging from 0.05–5 mg/ml on adhesion to human
umbilical vein endothelial cells (HUVEC). Monocyte adhesion is presented as a ratio of THP1 to HUVEC. Values are means of three independent
experiments, with standard deviations represented by vertical bars. Data were analysed using two-way analysis of variance (ANOVA) and significant
differences were identified using Tukey’s multiple comparisons post-hoc test. Statistical significant difference was set to P,0.05 for all analyses,
where * indicating significant different to TNF-a and # indicating significant different to negative control.
doi:10.1371/journal.pone.0095527.g004
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Figure 5. Effects of MOF on NF-kB mediated reporter gene expression. A) Dose-dependent inhibition of 5 h lipopolysaccharide (LPS)-
induced (1 mg/ml) NF-kB dependent reporter gene transcription by 30 min. pre-incubation of in vitro differentiated U937 macrophages with MOF
concentrations ranging from 0.05–5 mg/ml. One-way ANOVA was used to evaluate significant effects on reporter gene activity induced by MOF.
Significant differences between single LPS treatment and LPS combination treatment with MOF concentrations ranging from 0.05–5 mg/ml were
identified using Tuckey’s multiple comparisons post-hoc test. B) NF-kB dependent reporter gene expression in in vitro differentiated U937
macrophages exposed for 4, 5 or 6 h to LPS (1 mg/ml), with or without 60 min. pre-incubation with 5 mg/ml MOF. Two-way ANOVA and Bonferroni’s
post-hoc test were used to determine significant time- and MOF concentration-dependent effects on LPS-induced reporter gene activity. C) U937-
3xB-LUC monocytes were in vitro differentiated for 24 h with PMA (10 ng/ml) in the presence or absence of 5 mg/ml MOF. Upon replacement of the
medium in the different settings, cells were exposed to LPS for 6 h. One-way ANOVA was used to examine significant MOF effects on reporter gene
activity. Significant differences between single LPS treatment and LPS treatment following pretreatment with MOF were evaluated using Tuckey’s
multiple comparisons post-test. All values are means of three independent experiments, with standard deviations represented by vertical bars, *
indicating statistically significant differences assessed as described accordingly (P,0.05).
doi:10.1371/journal.pone.0095527.g005
Figure 6. CpG pyrosequencing-based validation of Illumina 450K array results. DNA methylation of blood leukocyte gDNA of 5 volunteers
was bisulfite treated and amplified by specific biotinylated primer sets for respectively a highly methylated CpG probe region of the CCR6 gene, a
medium methylated CpG probe region of the PCDHB4 gene and a weakly methylated CpG probe region of the MAFB gene. DNA methylation
intensities obtained from the different CpG probes by CpG pyrosequencing were plotted against the b-values (0,x,1, reflecting 0–100% DNA
methylation) obtained with the Illumina 450K array platform. Curve fitting reveals significant correlation of results between both platforms.
doi:10.1371/journal.pone.0095527.g006
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Figure 7. Intra-individual DNA methylation before and after MOF supplementation. Genome wide DNA methylation profiles of blood
leukocyte gDNA of 10 individuals were profiled by Illumina 450K CpG array. A) DNA methylation intensities (b-values 0,x,1, reflecting 0–100% DNA
methylation) of 450,000 CpG probes were plotted as dots along the X and Y axis to compare DNA methylation variation before and after 8 weeks
MOF supplementation in 2 representative subjects. B) DNA methylation intensities (b-values 0,x,1, reflecting 0–100% DNA methylation) of 450,000
CpG probes were plotted as dots along the X and Y axis to compare DNA methylation variation at baseline between 2 representative subjects. Green
lines represent cut-off values of 10% difference in b-values.
doi:10.1371/journal.pone.0095527.g007
Figure 8. Gene-specific variation in DNA methylation before and after MOF supplementation. Box- and whisker plots represent DNA
methylation as b-values (0,x,1, reflecting 0–100% DNA methylation) of 10 individuals before and after 8 weeks MOF supplementation for the
following genes: CXCL12 (A), SCRIB (B), PDGFRL (C), FERMT3 (D), ICAM1 (E) and VCAM1 (F). In figure 8A CpG sites have been sorted according to their
chromosome locus, including 59-UTR, promoter (transcription start site region (TSS)), gene body and 39-UTR region, as indicated in the figure. For
figures 8B - F, only the 59-UTR promoter region (TSS) has been included. No significant MOF effects on DNA methylation b-values could be observed
by one-way ANOVA and Bonferroni’s post-hoc test.
doi:10.1371/journal.pone.0095527.g008
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The capacity of polyphenols to modulate gene expression profiles
in circulating blood cells in humans has been described in a few
clinical trials [12,14]. These nutrigenomics studies have shown
that hesperidin, quercetin, resveratrol or isoflavones can modulate
the expression of 560 to over 4000 genes suggesting that the health
benefits of polyphenols in humans is probably dependent on their
genomic effects. Recently, the impact of the consumption of grape
seed extract containing resveratrol during 6 and 12 months was
studied on the expression of genes in peripheral blood mononu-
clear cells of type 2 diabetic and hypertensive medicated male
patients [37]. Using a nutrigenomic approach, over 4000 genes
have been differentially expressed upon the intervention which are
involved in inflammatory cytokine-mediated processes, cell move-
ment, cell signalling and cell trafficking. Compared to our study a
higher number of differentially expressed genes was observed
which might be due to differences in volunteers (patients versus
healthy subjects), the composition of the investigational com-
pounds, the doses used (300 and 600 mg/d versus 200 mg/d) and
the length of the study (6 and 12 months versus 8 weeks).
Comparison of the genes revealed only 145 common genes in both
studies (figure S1A). However, the pathways identified from
differentially expressed genes by means of KEGG database in our
study coincide with those reported by Tome´-Carneiro et al [37]
(figure S1B).
Bioinformatic analysis revealed that the differentially expressed
genes are involved in the regulation of different cellular processes.
The most overrepresented pathways are involved in chemotaxis,
cell adhesion, immune response and cell cycle. Chemokines and
adhesion molecules play important roles in leukocyte adhesion,
trans-endothelial migration and activation [38,39]. Among the
genes involved in chemotaxis and leukocyte infiltration is CXCL12
[40], which appeared to be down-regulated after 8 weeks MOF
supplementation. Together with CXCL12, a decrease in the
expression of SCRIB, a gene involved in chemotaxis and cell
migration could be observed [41]. Chemotaxis of circulating blood
cells is followed by their interaction with the vascular endothelium,
which presents a first event in atheroma plaque formation, and
requires the participation of different cell adhesion molecules.
Over 30 genes coding for cell adhesion molecules have been
identified in our study by means of gene ontology interpretation.
Among these genes, we observed a down-regulation of the
expression of FERMT3. This gene has been described as playing
a significant role in cell-cell adhesion. The loss of expression of this
gene resulted in abolishment of firm adhesion and arrest of
neutrophils on activated endothelial cells in vitro and in vivo, without
affecting selectin-mediated rolling [42]. Furthermore, the interac-
tions between circulating blood cells and endothelial cells can also
be regulated by interaction of leukocytes with platelets, a process
that involves platelet-derived growth factors (PDGFs) [43]. In our
study, we observed that a regular consumption of MOF
significantly decreased the expression of PDGF receptors
(PDGFRL), suggesting potential lower interactions of leukocytes
with platelets and consequently endothelial cells. Taken together,
the bioinformatic analyses showed that consumption of MOF
modulate expression of genes involved in chemotaxis, adhesion
and platelet adhesion, suggesting potential lower adhesion of
circulating blood cells to the endothelium. In the objective to
substantiate this finding on a cellular level, we exposed human
monocytes to MOF and co-incubated them with vascular
endothelial cells in vitro. In agreement with our nutrigenomic
results, a significant decreased adhesion of monocytes pre-exposed
to MOF could be observed at the endothelial cells compared to
control. The potential of grape seed extract to decrease adhesion
of monocytes (THP-1) to HUVECs has been reported recently,
however at concentrations ranging from 50 to 100 mg/ml [44].
These concentrations are higher than the concentrations used in
our study. Our results emphasize the capacity of grape seed–
derived MOF to decrease the adhesion of immune cells to the
vascular endothelium and potentially lower infiltration of these
immune cells into the vascular wall, which is an initial step in
atherosclerosis development. It has been reported that supple-
mentation of the diet with catechin, a flavanol monomer present in
MOF, results in lower atherosclerosis development in apolipopro-
tein E-deficient mice [45]. It could be postulated that the regular
consumption of MOF could decrease blood cell infiltration into
the vasculature and potentially protect against atherosclerotic
lesions in humans.
Our bioinformatic data also revealed that over 30 differentially
expressed genes are involved in different processes related to
inflammation. The role of chronic inflammation in the promotion,
initiation and development of chronic diseases, such as cancer
[46], cardiovascular disease [47] or osteoporosis [48] has been
described. In our study, among the differentially expressed genes
involved in inflammatory processes is the gene coding for the pro-
inflammatory cytokine IL2, of which the expression has been
down-regulated by the MOF supplementation. Together with IL2,
we also observed a decrease in the expression of a subunit of its
receptor, the IL2RB gene. These inflammation-related genes, as
well as some of the cell adhesion molecules, are regulated by the
transcription factor NF-kB. Bioinformatic analyses of the nutrige-
nomic data identified several transcription factors potentially
involved in the regulation of the expression of differentially
expressed genes, among which is NF-kB. This suggests that NF-kB
is a potential target by which MOF exert their anti-inflammatory
effects in circulating blood cells. Interestingly, our nutrigenomic
data also revealed an increase in the expression of the gene coding
for NFKBIA, the endogenous inhibitor of NF-kB. A previous in vivo
study in an atherosclerotic ApoE mouse model identified NF-kB as
a major upstream regulator in leukocyte adhesion and transen-
dothelial migration through the vascular endothelium [7].
Moreover, NF-kB activity in peripheral blood mononuclear cells
(PBMCs) from smokers has been found to be significantly higher
than in PBMCs from non-smokers [49]. In order to corroborate a
direct effect of MOF on NF-kB we performed NF-kB reporter
gene studies in an inflammatory human monocyte/macrophage
cell model. The experiments revealed a dose- and time-dependent
repression of NF-kB luciferase expression in the presence of MOF.
As such, MOF may trigger synergistic cardio-protective effects by
reducing NF-kB activity in both, monocytes and endothelial cells,
resulting in attenuation of cell adhesion and transendothelial
migration programs. Taken together, the nutrigenomic data
elucidated numerous genes which are modulated by an 8 weeks
supplementation with MOF in blood cells. The affected genes are
involved in different cellular processes that regulate interactions
with the endothelium and inflammation. We also found that
regular consumption of MOF alters gene expression to a
potentially protective cardiovascular profile. These results further
unravel the molecular mechanisms of the vascular health benefits
provided by dietary flavanols in humans.
Although DNA methylation effects have been described in
peripheral leukocytes of humans at cardiovascular risk upon
consumption of dietary polyphenols and cruciferous vegetables
[25], we were unable to identify common DNA methylation
changes in our group of subjects after 8 weeks MOF supplemen-
tation. One of the main reasons for this is the high inter-individual
basal variation in DNA methylation in the recruited smokers. Of
special note, tobacco smoke is known to trigger genome-wide
changes in DNA methylation and may mask diet-induced effects of
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relatively short (i.e. compared to lifespan) intervention studies
[50,51,52]. In addition to smoking, age or clinical parameters
(blood pressure, pulse, LDL/HDL ratio, plasma CRP, BMI,
serum cholesterol) may introduce variation in genome-wide DNA
methylation patterns [50,51,52,53,54,55,56,57,58,59]. Consider-
ing the stochastic nature of DNA methylation changes, we cannot
exclude that a relative short diet intervention (8 weeks) is not
sufficient to trigger a 10% change in DNA methylation (our cut-off
criterion for differential methylation) as compared to DNA
methylation changes following many years (.15 y) of heavy
smoking, hypertension and/or aging. Indeed, minor diet-induced
DNA methylation changes of 3–6% of the NR3C1 gene have been
linked to hyperhomocysteinemia in cardiovascular disease [60]. In
a soy diet study in monkeys, it was observed that diet-specific DNA
methylation changes may vary between the tissue: most pro-
nounced DNA methylation effects were found in liver and muscle,
whereas blood remained unaffected [61,62]. As such, blood
samples may not represent the most sensitive tissue to evaluate
specific nutritional epigenetic changes. Analyses may be further
complicated by different subtypes of blood cells [63,64,65].
Alternatively, timing of dietary exposure may be another critical
parameter, as prenatal exposure to genistein was found to exert
lifelong alterations in gene expression and DNA methylation of
hematopoietic cells [66,67].
In conclusion, our study revealed that a daily supplementation
with 200 mg MOF over 8 weeks modulates the expression of genes
associated with cardiovascular disease pathways without major
specific changes of their DNA methylation state. A strong inter-
individual variation in leukocyte DNA methylation may conceal
the subtle epigenetic response to dietary flavanols. This calls for
studies with larger sample sizes to reveal an epigenetic role of
flavanols in cardioprotection. Despite the lack of significant
changes in DNA methylation, we could demonstrate that the
modulation of gene expression appears to contribute to the
vascular health effects of MOF observed in humans.
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